4th International Conference on Biochemistry & Metabolomics
Los Angeles, USA
Scripps Research Institute, USA
Dr. Vaughn Smider received his M.D. and Ph.D. degrees from Stanford University School of Medicine. He is currently on the faculty of the Scripps Research Institute in the Cell and Molecular Biology Department, and is also the Chief Scientific Officer of Sevion Therapeutics. Dr. Smider’s research focuses on both basic biology and applied technology in the antibody field, including antibody genetics, structure, engineering and development.